Jason N. Butler
Stock Analyst at JMP Securities
(1.93)
# 3,176
Out of 5,005 analysts
7
Total ratings
57.14%
Success rate
2.12%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Jason N. Butler
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ABVX ABIVAX Société Anonyme | Maintains: Market Outperform | $95 → $114 | $83.92 | +35.84% | 1 | Sep 25, 2025 | |
| CRMD CorMedix | Reiterates: Market Outperform | $22 | $11.34 | +94.00% | 1 | Sep 9, 2025 | |
| CYTK Cytokinetics | Reiterates: Market Outperform | $78 | $56.97 | +36.91% | 1 | Sep 2, 2025 | |
| PGEN Precigen | Maintains: Market Outperform | $6 → $8 | $3.25 | +146.15% | 1 | Aug 19, 2025 | |
| ZVRA Zevra Therapeutics | Maintains: Market Outperform | $19 → $18 | $9.75 | +84.62% | 1 | Aug 13, 2025 | |
| ACAD ACADIA Pharmaceuticals | Maintains: Market Outperform | $30 → $35 | $21.80 | +60.55% | 1 | Aug 7, 2025 | |
| HALO Halozyme Therapeutics | Maintains: Market Outperform | $91 → $78 | $68.98 | +13.08% | 1 | Aug 6, 2025 |
ABIVAX Société Anonyme
Sep 25, 2025
Maintains: Market Outperform
Price Target: $95 → $114
Current: $83.92
Upside: +35.84%
CorMedix
Sep 9, 2025
Reiterates: Market Outperform
Price Target: $22
Current: $11.34
Upside: +94.00%
Cytokinetics
Sep 2, 2025
Reiterates: Market Outperform
Price Target: $78
Current: $56.97
Upside: +36.91%
Precigen
Aug 19, 2025
Maintains: Market Outperform
Price Target: $6 → $8
Current: $3.25
Upside: +146.15%
Zevra Therapeutics
Aug 13, 2025
Maintains: Market Outperform
Price Target: $19 → $18
Current: $9.75
Upside: +84.62%
ACADIA Pharmaceuticals
Aug 7, 2025
Maintains: Market Outperform
Price Target: $30 → $35
Current: $21.80
Upside: +60.55%
Halozyme Therapeutics
Aug 6, 2025
Maintains: Market Outperform
Price Target: $91 → $78
Current: $68.98
Upside: +13.08%